Spectrum Pharma: Zevalin Has Blockbuster Potential [View article]
Justin, i understand, but you and Spectrum can make this same case until you're all blue in the face but its still not going to sell $100M or even $50M or even $25M in 2010.
Spectrum Pharma: Zevalin Has Blockbuster Potential [View article]
Justin, Do you understand that if Z does half or even one quarter of your $100M hopes it would be surprising? Make sure to provide an update in February.
Spectrum Pharma: Zevalin Has Blockbuster Potential [View article]
Aren't you paying attention to what Spectrum has been saying about Zevalin? To refresh they said reversing its long term decline in sales would be a win. $100M in sales guidance announced in February? Take a cold shower pal.
Spectrum Pharma: Zevalin Has Blockbuster Potential [View article]
Please ask Dr Kallas why if Zevalin were such a great drug why is Spectrum zevalin's 4th owner and why were they were able to buy it for next to nothing most recently? Nowhere in Doctor Kallas's comments did it indicate he understood this is a drug which has been available for a number of years. Why do you think Spectrum raised as much money as possible, could it be because they realize zevalin sales will never amount to much?
Access Pharma: MuGard, Pipeline Make for Appealing Acquisition Possibilities [View article]
Do you realize Macrochem was controlled by......the Access CEO and resident clown, Jeff Davis? Talk about self dealing. You should note that when you use Macrochem holders selling as your excuse for weakness.
Your examples of Facet and Cougar as proof Access will be acquired for rich money is misplaced. Havrilla's ass this thing will be acquired for $200-240M.
Spectrum Pharma: Zevalin Has Blockbuster Potential [View article]
Spectrum Pharma: Zevalin Has Blockbuster Potential [View article]
Spectrum Pharma: Zevalin Has Blockbuster Potential [View article]
Spectrum Pharma: Zevalin Has Blockbuster Potential [View article]
Access Pharma: MuGard, Pipeline Make for Appealing Acquisition Possibilities [View article]
Your examples of Facet and Cougar as proof Access will be acquired for rich money is misplaced. Havrilla's ass this thing will be acquired for $200-240M.
Cell Therapeutics Likely to Move Higher on Significant Cancer Study News [View article]
Cell Therapeutics Reemerging [View article]